Enregistrement - Lobbyistes salariés d'entreprises

Objets

• Commerce international
• Développement régional
• Impôts et finances
• Industrie
• Marchés publics
• Propriété intellectuelle
• Questions touchant les consommateurs
• Recherche et développement
• Relations internationales
• Santé
• Sciences et technologies

Détails sur l'objet

Politique ou Programme

• Federal Public Drug Plans, with respect to the reimbursement of therapeutic products for Federal plan beneficiaries
• Health Canada’s policies, program and guidelines related to the management, prevention, mitigation and notification of drug shortages and discussion on COVID19 potential impacts
• Monitoring and engaging on the Government’s commitment (Budget, SFT, Fall Economic Update) to create a national strategy for high-cost drugs for rare diseases; create a new Canadian Drug Agency; and the implementation of national, universal pharmacare.
• Monitoring and engaging the Government and Parliamentarians on policies and programs related to Canada's biomanufacturing strategy
• Monitoring and engaging the Government and Parliamentarians on policies and programs that would provide greater clarity and predictability in the tax outcomes and improvements to tax measures such as the Manufacturing & Processing (M&P) credit and the Scientific Research & Developmental (SR&ED).
• The Department of Innovation, Science and Economic Development and the Innovation Agenda for the life sciences sector: policy or program initiatives to support life science research and development conducted in Canada and manufacturing capability.

Politique ou Programme, Proposition législative, Projet de loi ou résolution, Règlement

• Consider amendments to the Food and Drugs Act, or the Export and Imports Permits Act (Export Control List) or any other legislative and regulatory means in order to protect the Canadian supply of drugs in light of potential importation legislation in the United States.

Politique ou Programme, Règlement

• Patented Medicine Prices Review Board (PMPRB) amendments to the Patented Medicines Regulations and the related proposed guidelines.
• Regulations, policies and programs related to the reimbursement recommendations decision-making process and framework done by the Canadian Agency for Drugs and Technologies in Health (CADTH)/Common Drug Review as well as the review times and processes conducted by Health Canada for the purpuse of obtaining a notice of compliance.

Politique ou Programme, Subvention, Contribution ou autre avantage financier

• Advocacy to maintain and increase funding for the National Immunization Strategy and discussions on vaccine procurement.

Proposition législative, Projet de loi ou résolution, Règlement

• Monitoring and engaging on the Act respecting certain measures in response to COVID-19 and the changes to the Patent Act, including eventual regulations and guidelines, formally known as Bill C-13, An Act respecting certain measures in response to COVID-19 .

Subvention, Contribution ou autre avantage financier

• Discussions on the procurement of a COVID19 vaccine candidate

Techniques de communication

• Communication écrite
• Communication orale
• Appel au grand public

Institutions gouvernementales

• Affaires mondiales Canada (AMC)
• Agence de la santé publique du Canada (ASPC)
• Agence de promotion économique du Canada atlantique (APECA)
• Agence du revenu du Canada (ARC)
• Anciens Combattants Canada (ACC)
• Bureau du Conseil privé (BCP)
• Cabinet du Premier ministre (CPM)
• Chambre des communes
• Conseil d'examen du prix des médicaments brevetés (CEPMB)
• Défense nationale (MDN)
• Développement économique Canada pour les régions du Québec
• Diversification de l'économie de l'Ouest Canada (DEO)
• Emploi et Développement social Canada (EDSC)
• Finances Canada (FIN)
• Innovation, Sciences et Développement économique Canada (ISDE)
• Instituts de recherche en santé du Canada (IRSC)
• Justice Canada (JC)
• Santé Canada (SC)
• Secrétariat des affaires intergouvernementales (AIG)
• Secrétariat du Conseil du Trésor du Canada (SCT)
• Sénat du Canada
• Services aux Autochtones Canada (SAC)
• Services publics et Approvisionnement Canada (SPAC)

Adresse :
17,300 TRANS-CANADA HIGHWAY
KIRKLAND, QC  H9J 2M5
Canada

Numéro de téléphone : 514-693-4264

Renseignements sur la société mère